Sunshine Biopharma Inc. (NASDAQ: SBFM)
$0.33
-0.0125 ( -3.70% ) 761.6K
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
Market Data
Open
$0.33
Previous close
$0.34
Volume
761.6K
Market cap
$6.31M
Day range
$0.32 - $0.35
52 week range
$0.28 - $64.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 1 | Jul 11, 2024 |
8-k | 8K-related | 14 | Jul 02, 2024 |
8-k | 8K-related | 14 | Jul 01, 2024 |
pre | Proxies and info statements | 1 | Jul 01, 2024 |
8-k | 8K-related | 14 | Jun 11, 2024 |
8-k | 8K-related | 14 | Jun 07, 2024 |
8-k | 8K-related | 16 | May 22, 2024 |
10-q | Quarterly Reports | 62 | May 20, 2024 |
nt | Quarterly Reports | 1 | May 15, 2024 |
8-k | 8K-related | 14 | May 08, 2024 |